These kits are developed by Siemens healthcare, Transasia diagnostics, and JITM C Genes.

The Central Drugs Standard Control Organization (CDSCO) has approved the manufacturing of three indigenously developed kits for detecting mpox (previously known as monkeypox). The approval criteria was a sensitivity and specificity of over 95%, the drug regulator said.

These kits are developed by Siemens healthcare, Transasia diagnostics, and JITM C Genes.

“These RT-PCR kits use fluid samples from pox rashes to examine the virus. These kits were validated by the ICMR, but there’s no commercial manufacturing, as it is not required,” a Health Ministry official said.

These three approved kits are among the six validated by the ICMR to detect the viral infection.

source/content: indianexpress.com (headline edited)